Stockscreener 앱 받기
93.90
0.92%
1.10
전일 마감가:
$92.80
열려 있는:
$93.84
하루 거래량:
2.13M
Relative Volume:
0.18
시가총액:
$163.12B
수익:
$45.13B
순이익/손실:
$6.28B
주가수익비율:
26.16
EPS:
3.5895
순현금흐름:
$7.40B
1주 성능:
+1.01%
1개월 성능:
-9.94%
6개월 성능:
-26.03%
1년 성능:
-27.70%
1일 변동 폭
$93.51
$94.79
1주일 범위
$90.72
$94.79
52주 변동 폭
$90.72
$139.06
애보트 래버러토리스 Stock (ABT) Company Profile
명칭
Abbott Laboratories
전화
(224) 667-6100
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT vs SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
93.87 | 161.26B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
323.58 | 126.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
82.47 | 106.46B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
59.07 | 89.10B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
81.79 | 48.12B | 6.30B | 1.07B | 1.34B | 1.8406 |
애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-22 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2025-10-10 | 개시 | The Benchmark Company | Buy |
| 2025-07-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-06-16 | 개시 | Leerink Partners | Market Perform |
| 2024-10-08 | 개시 | Oppenheimer | Outperform |
| 2024-09-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-30 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-21 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 재확인 | Barclays | Overweight |
| 2023-04-20 | 재확인 | Bernstein | Outperform |
| 2023-04-20 | 재확인 | JP Morgan | Overweight |
| 2023-04-20 | 재확인 | Raymond James | Outperform |
| 2023-04-20 | 재확인 | UBS | Buy |
| 2023-04-20 | 재확인 | Wolfe Research | Underperform |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-10-26 | 개시 | Mizuho | Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-27 | 재확인 | Credit Suisse | Outperform |
| 2022-01-27 | 재확인 | Morgan Stanley | Overweight |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | UBS | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-27 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-01-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-06-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-02-07 | 재확인 | BofA/Merrill | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-11-30 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-01-30 | 재확인 | Citigroup | Neutral |
| 2018-01-25 | 재확인 | Stifel | Buy |
| 2018-01-25 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-19 | 재확인 | Stifel | Buy |
모두보기
애보트 래버러토리스 주식(ABT)의 최신 뉴스
Late-Breaking AFib Data on Pulsed Field Ablation Could Be A Game Changer For Abbott (ABT) - simplywall.st
Point of Care Diagnostics Market | Abbott Laboratories, BD, Danaher Corp, Nova Biomedical Corporation etc. - openPR.com
Top Abbott Executive Makes Bold Insider Move at Abbott Laboratories - TipRanks
Abbott Laboratories (ABT) Announces New Board Member and Adoptio - GuruFocus
Proposed RSU sales by ABT insider via UBS (NYSE: ABT) on 04/27/2026 - Stock Titan
Abbott Laboratories EVP and CFO Philip Boudreau buys $201,300 in stock By Investing.com - Investing.com South Africa
Abbott (NYSE: ABT) CFO adds 2,200 shares in open-market buy - Stock Titan
Abbott Expands Board and Enhances Equity Incentive Programs - TipRanks
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott (NYSE: ABT) holders back 2026 stock plan, expand board - Stock Titan
Abbott's Strong AFib, Cardiac Device Data Fuels Heart-Rhythm Device Buzz - Benzinga
Has the Abbott Laboratories sell-off finally created an entry point? - MSN
Abbott (ABT) Reports Promising Data on Heart Treatment Technologies - GuruFocus
Assessing Abbott (ABT) Valuation After New Cardiac Trial Results And Recent Share Price Pullback - simplywall.st
Teachers Retirement System of The State of Kentucky Trims Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Bought by Vanguard Group Inc. - MarketBeat
Commentary: There is a hidden cost to the Abbott verdict for premature babies - Daily Republic
Concurrent Investment Advisors LLC Purchases 17,137 Shares of Abbott Laboratories $ABT - MarketBeat
Why Abbott Laboratories stock tumbled on Thursday - MSN
Cardiac treatment advancements see Abbott Laboratories stock down 1.44% amid oversold signals and bearish pressure - Traders Union
Abbott Laboratories Q1 2026 Earnings: $2B CGM Quarter, 65% Upside Priced In - TIKR.com
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 - Abbott MediaRoom
4 new studies test Abbott devices for irregular heartbeats - Stock Titan
Abbott Laboratories cuts outlook, says mild flu season hurt sales - MSN
M&T Bank Corp Decreases Holdings in Abbott Laboratories $ABT - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Is There Now An Opportunity In Abbott Laboratories (ABT) After Recent Share Price Pullback? - simplywall.st
A Look At Abbott Laboratories ABT Valuation After New Cancerguard Early Cancer Detection Data - Yahoo Finance
Abbott Laboratories stock underperforms Friday when compared to competitors - MarketWatch
Daiwa Downgrades Abbott Laboratories (ABT), Sees Limited Upside - Yahoo Finance
Abbott Laboratories: Buying A Healthcare Giant On Sale (NYSE:ABT) - Seeking Alpha
Arizona State Retirement System Sells 13,152 Shares of Abbott Laboratories $ABT - MarketBeat
ABT Price History for Abbott Laboratories Stock - Barchart.com
Why Abbott’s S&P 500 Fund Oncology Story Is Turning Heads? - Kalkine Media
Abbott CancerGuard Data And AACR Award Add To Oncology Growth Story - simplywall.st
Catheters Market Report 2025-2030, Profiles and Strategy Analysis of Leading PlayersAbbott Laboratories, Boston Scientific, Medtronic, Terumo, and B. Braun - Yahoo Finance
Abbott Laboratories $ABT Shares Purchased by B. Metzler seel. Sohn & Co. AG - MarketBeat
ABT (Abbott Laboratories) reports narrow Q1 2026 EPS miss as positive investor sentiment pushes shares up 1.4 percent.Open Stock Signal Network - Xã Thanh Hà
Abbott Laboratories Just Got Interesting: Dividend Yield Near 3% Signals Opportunity (DCA) (NYSE:ABT) - Seeking Alpha
Coagulation Analyzer Market Size to Reach a Valuation of USD 7.87 Billion by 2035; Increasing Incidence of Blood Disorders to Propel Market Expansion Globally | SNS Insider - GlobeNewswire Inc.
Abbott Laboratories (ABT) Tops List of Oversold Healthcare Stocks - GuruFocus
Universal Beteiligungs und Servicegesellschaft mbH Sells 159,473 Shares of Abbott Laboratories $ABT - MarketBeat
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA) - Seeking Alpha
Abbott Laboratories (NYSE:ABT) Downgraded by Daiwa Securities Group to Neutral - MarketBeat
KLP Kapitalforvaltning AS Cuts Stake in Abbott Laboratories $ABT - MarketBeat
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More - 24/7 Wall St.
TABR Capital Management LLC Makes New $7.36 Million Investment in Abbott Laboratories $ABT - MarketBeat
Moran Wealth Management LLC Sells 73,546 Shares of Abbott Laboratories $ABT - MarketBeat
ABT Stock Price, Quote & Chart | ABBOTT LABORATORIES (NYSE:ABT) - ChartMill
Abbott has positive drug-eluting scaffold data - Drug Delivery Business
애보트 래버러토리스 (ABT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.72%
자본화:
|
볼륨(24시간):